| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 01/03/2008 | US20080004427 Methods for arbitrary peptide synthesis |
| 01/03/2008 | US20080004326 Method of Obtaining Idolocarbazoles Using Biosynthetic Rebeccamycin Genes |
| 01/03/2008 | US20080003645 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/03/2008 | CA2657973A1 Therapeutic compounds |
| 01/03/2008 | CA2654375A1 Therapeutic compounds |
| 01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 01/02/2008 | EP0973938B1 The use of nadph and nadh analogs in the measurement of enzyme activities and metabolites |
| 01/02/2008 | EP0819133B1 Covalently linked oligonucleotide minor groove binder conjugates |
| 01/02/2008 | CN101096380A Method for purifying citicoline from biotransformation or multienzyme reaction liquid |
| 01/02/2008 | CN101096379A Novel highly-solid selectively synthesizing gemcitabine process and intermediate |
| 01/02/2008 | CN100358533C Medicinal composition for drug-induced neuropathy |
| 01/01/2008 | US7314928 Process for manufacturing morpholino-nucleotides, and use thereof for the analysis of and labelling of nucleic acid sequences |
| 01/01/2008 | US7314923 The present invention relates to novel oligonucleotide analogues, which exhibit antisense or antigene activity having excellent stability, or exhibit excellent activity as a detection agent (probe) for a specific gene or as a primer |
| 01/01/2008 | US7314746 Apparatus and method for preparative scale purification of nucleic acids |
| 12/27/2007 | WO2007149891A2 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 12/27/2007 | WO2007124123A3 Method of treating inflammation |
| 12/27/2007 | WO2007120972A3 Method to treat sickle cell disease |
| 12/27/2007 | US20070299033 stavudine:melamine co-crystal or stavudine:2-aminopyridine co-crystal; therapeutics; shelf-life, bioavailability |
| 12/27/2007 | US20070298411 Cell Culture |
| 12/27/2007 | US20070298120 Photoreactive Compound Specifically Binding to Calcium Binding Proteins |
| 12/27/2007 | CA2655904A1 Prodrugs of 5-amino-3-(3'-deoxy-.beta.-d-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione |
| 12/27/2007 | CA2652633A1 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 12/26/2007 | EP1870103A2 Use of uridine in combination with choline for the treatment of memory disorders |
| 12/26/2007 | EP1654270B1 Process for preparing 2',3'-didehydro-2',3'-dideoxynucleosides and 2',3'-dideoxynucleosides |
| 12/26/2007 | EP1567045A4 Methods for diagnosing the presence or stage of cancer |
| 12/26/2007 | CN101092441A Method for synthesizing nelarabine |
| 12/26/2007 | CN100357308C Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 12/25/2007 | US7312326 Fluorescent labeled nucleotide derivatives |
| 12/25/2007 | US7312038 Photocleavable bioreactive agents |
| 12/21/2007 | WO2007145593A1 Conformationally constrained 2' -n,4' -c-ethylene-bridged thymidine (aza-ena-t) |
| 12/21/2007 | WO2007144168A1 Enzymatic process for preparation of 5'-monophosphate-nucleotides |
| 12/21/2007 | WO2007121883A3 1,4:3,6-dianhydromannitol derivatives and use thereof |
| 12/21/2007 | WO2007104793A3 Process for preparing l-nucleic acid derivatives and intermediates thereof |
| 12/21/2007 | WO2007059330A3 Cubane nucleoside analogs |
| 12/21/2007 | WO2007038860A8 Odcase inhibitors as anti-virals and antibiotics |
| 12/21/2007 | WO2006050161A3 Therapeutic furopyrimidines and thienopyrimidines |
| 12/21/2007 | WO2005110455A3 Combination therapy for treating hepatitis virus infection |
| 12/20/2007 | US20070293452 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial |
| 12/20/2007 | US20070293444 Novel Nucleoside Transport Inhibitors |
| 12/19/2007 | EP1866324A1 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
| 12/19/2007 | EP1866319A1 Phosphono-pent-2-en-1-yl nucleosides and analogs |
| 12/19/2007 | EP1865926A2 Solid oral dosage form of valopicitabine (val-mcyd) and method of preparing it |
| 12/19/2007 | EP1709057B1 Synthesis of spongosine |
| 12/19/2007 | EP1496911B1 Use of a combination comprising a2a adenosine receptor agonists and anti-pathogenic agents for the treatment of inflammatory diseases |
| 12/19/2007 | CN101089010A 2'-fluoroncucleosides |
| 12/19/2007 | CN100355769C 2úº-methoxy adenosine preparation method |
| 12/18/2007 | US7309785 Attached to a heterologous, non-Cry35 protein (Bacillus sphaericus insecticidal toxin) or a second, different Cry35 protein; inhibiting a rootworm pest |
| 12/18/2007 | US7309696 Compositions and methods for targeting cancer cells |
| 12/13/2007 | WO2007090553B1 Compounds useful as agonists of a2a adenosine receptors, cosmetic compositions with a2a agonists and a method for using the same |
| 12/13/2007 | US20070287832 Linkers and co-coupling agents for optimization of oligonucleotide synthesis and purification on solid supports |
| 12/13/2007 | US20070287831 5'-modified bicyclic nucleic acid analogs |
| 12/12/2007 | EP1863827A1 Hydrogels for the controlled release of bioactive materials |
| 12/12/2007 | EP1863826A1 Process for the preparation of 4,6-disubstituted-tetrahydro-furo, thieno, pyrrolo and cyclopenta-[3,4][1,3]dioxoles |
| 12/12/2007 | CN101085798A Cryogel adsorption chromatography separation method for cytidine triphosphate |
| 12/12/2007 | CN101085797A Cryogel adsorption chromatography separation method for adenosine triphosphate |
| 12/12/2007 | CN100354296C Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same and method forproducing said compound |
| 12/12/2007 | CN100354295C Organic compounds of 2'-o-trisubstituted siloxy methyl ribonucleoside derivatives and their preparation |
| 12/11/2007 | US7307166 8-Substituted purines; ring-cleaved aldose (guanosine 2',3' dialcohol); inflammatory diseases and bacterial infections; modifying hematopoiesis in animals with damage caused by irradiation, chemotherapy, poisoning; improve host leukocyte-mediated defenses against infection. |
| 12/11/2007 | US7307065 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents |
| 12/11/2007 | CA2171618C Purine nucleoside phosphorylase gene therapy for human malignancy |
| 12/06/2007 | WO2007117760A3 Preparation of gemcitabine |
| 12/06/2007 | WO2007062168A3 Methods and compositions for the treatment of gastrointestinal disorders |
| 12/06/2007 | US20070281902 5-{6-[N'-(furan-2-carbonyl)-hydrazino]-9H-purin-9-yl}-3,4-dihydroxy-tetrahydrofuran-2-carboxylic acid ethylamide; septic shock; cystic fibrosis;sexual impotency; diarrhea; hyperplasia; hypotensive agents; arteriosclerosis; cardiovascular disorders; stress for imaging of ischemic coronary |
| 12/06/2007 | US20070280946 Antibody to 5' -Deoxy-5' - Methylthioadenosine And Uses Thereof |
| 12/05/2007 | EP1861412A1 Adenosine derivatives having a2a receptor activity |
| 12/05/2007 | CN100352827C Flavin adenine dinucleotide disodium salt purification method |
| 12/04/2007 | US7304043 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B |
| 12/04/2007 | US7303876 Contacting with cationic surfactant (cetyltrimethylammonium bromide); ribonuclease inhibitors; for sampling DNA/RNA in tissues |
| 12/04/2007 | CA2445744C Antiviral nucleoside derivatives |
| 12/04/2007 | CA2223894C Dinucleotides useful for the treatment of lung disease |
| 11/29/2007 | WO2007136817A2 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 11/29/2007 | WO2007135195A1 Ectonucleotidase inhibitors |
| 11/29/2007 | WO2007135134A1 Crystalline a and b forms of a maleate salt of 5-amino-3- (2 ', 3 '-di-o-acetyl-beta-d-ribofuranosyl) -3h-thiaz0l0 [4, 5-d] pyrimidin-2-one |
| 11/29/2007 | WO2007038757A3 Methods and compositions for non-invasive assessment of gene expression |
| 11/29/2007 | WO2007027248A3 3', 5' - cyclic nucleoside analogues for treatment of hcv |
| 11/29/2007 | US20070276146 Adenine modified silica-based catalyst, a process for the preparation and use there for the production of cyclic carbonates |
| 11/29/2007 | US20070276139 Substituted Pixyl Protecting Groups for Oligonucleotide Synthesis |
| 11/29/2007 | US20070275912 Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase |
| 11/29/2007 | US20070275871 Epo Mimetic Peptides and Fusion Proteins |
| 11/29/2007 | US20070275436 polypeptide comprising an amino acid sequence having polyene polyketide synthase activity; involved in the biosynthesis of novel polyketides, inhibitors of fungal cell growth and cancer cell growth |
| 11/29/2007 | US20070275387 Photocleavable Fluorescent Nucleotides for Dna Sequencing on Chip Constructed by Site-Specific Coupling Chemistry |
| 11/29/2007 | CA2669813A1 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 11/29/2007 | CA2652857A1 Crystalline a and b forms of a maleate salt of 5-amino-3- (2 ', 3 '-di-o-acetyl-beta-d-ribofuranosyl) -3h-thiazolo [4, 5-d] pyrimidin-2-one |
| 11/28/2007 | EP1860115A1 Oligonucleotide derivative, probe for detection of gene, and dna chip |
| 11/28/2007 | EP1860114A1 Nitroguanosine-3 ,5 -cyclic monophosphate and protein kinase g activator |
| 11/28/2007 | EP1860113A1 Ectonucleotidase inhibitors |
| 11/28/2007 | CN101080417A Amide prodrug of gemcitabine, compositions and use thereof |
| 11/28/2007 | CN100351389C Non-homogeneous systems for resolution of enantiomeric mixtures |
| 11/28/2007 | CN100351264C Antiviral nucleoside derivatives |
| 11/28/2007 | CN100351243C Peptide nucleic acid oligomers from 1-benzenesulfonyl-3-amino acid side chain-4-(2-nucleobase(acetyl))-piperazin-2-ones |
| 11/27/2007 | US7301016 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosing and treating cell proliferative disorders; animal models |
| 11/27/2007 | US7300923 Partial and full agonists of A1 adenosine receptors |
| 11/22/2007 | WO2007132831A1 Method of producing s-adenosyl-l-methionine-containing dry yeast having excellent storage stability, the product thereof and composition for oral intake |
| 11/22/2007 | WO2007056217A3 Drug-eluting stents coated with non-nucleotide p2y12 receptor antagonist compound |
| 11/22/2007 | US20070270582 A system capable of releasing a specific molecule by external stimulation such as oxidation and photoirradiation without impairing a target nucleic acid; useful in gene analysis and for therapy and diagnosis of various diseases |
| 11/22/2007 | US20070270374 2'-C-Methyl-Ribofuranosyl Cytidine Prodrugs, Pharmaceutical Compositions and Uses Thereof |
| 11/22/2007 | US20070270373 N-Cyclopropyl 2-{3-[1-(4-nitrophenyloxycarbonyl)-4-piperidinyl]-1-propyn-1-yl}adenosine-5'-uronamide; myocardial perfusion, autoimmune diseases, inflammation, allergic diseases, skin diseases, infectious diseases, wasting diseases, organ transplantation |
| 11/22/2007 | US20070270370 Novel bicyclonucleoside analogues |
| 11/22/2007 | US20070270335 Methods for alleviating deleterious effects of 3-deoxyglucosone |